BNR (Burning Rock Biotech Limited American Depositary Shares) Stock Analysis - Analyst Ratings

Burning Rock Biotech Limited American Depositary Shares (BNR) is a publicly traded Healthcare sector company. As of May 21, 2026, BNR trades at $17.25 with a market cap of $176.12M and a P/E ratio of 0.00. BNR moved +0.00% today. Year to date, BNR is -31.78%; over the trailing twelve months it is +473.88%. Its 52-week range spans $2.18 to $41.72. Rallies surfaces BNR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate BNR?

The average price target is $0.00.

BNR Key Metrics

Key financial metrics for BNR
MetricValue
Price$17.25
Market Cap$176.12M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$41.72
52-Week Low$2.18
Volume0
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

BNR Analyst Consensus

BNR analyst coverage data. Average price target: $0.00.

Latest BNR News

Recent BNR Insider Trades

  • Han Yusheng bought 314.87K (~$5.47M) on Mar 31, 2026.

Common questions about BNR

What do analysts rate BNR?
The average price target is $0.00.
Does Rallies show BNR price targets?
Yes. Rallies tracks BNR analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is BNR research on Rallies investment advice?
No. Rallies provides research, data, and educational context for BNR. It does not provide personalized investment advice.
BNR

BNR